Description
The CONSORT-style flowchart of the synbiotic study protocol is displayed, detailing patient enrollment, randomization, and follow-up through 8 weeks.
Figure 5
FlowchartSource Paper
The Effectiveness of Synbiotic Preparation Containing Lactobacillus and Bifidobacterium Probiotic Strains and Short Chain Fructooligosaccharides in Patients with Diarrhea Predominant …Cite This Figure
![Figure 5: The CONSORT-style flowchart of the synbiotic study protocol is displayed, detailing patient enrollment, randomization, and follow-up through 8 weeks.]() > Source: Barbara Skrzydło-Radomańska et al. "The Effectiveness of Synbiotic Preparation Containing Lactobacillus and Bifidoba." *Nutrients*, 2020. PMID: [32635661](https://pubmed.ncbi.nlm.nih.gov/32635661/)
<figure> <img src="" alt="The CONSORT-style flowchart of the synbiotic study protocol is displayed, detailing patient enrollment, randomization, and follow-up through 8 weeks." /> <figcaption>Figure 5. The CONSORT-style flowchart of the synbiotic study protocol is displayed, detailing patient enrollment, randomization, and follow-up through 8 weeks.<br> Source: Barbara Skrzydło-Radomańska et al. "The Effectiveness of Synbiotic Preparation Containing Lactobacillus and Bifidoba." <em>Nutrients</em>, 2020. PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/32635661/">32635661</a></figcaption> </figure>
Preuves associées
B
Bifidobacterium longum pour Irritable Bowel Syndrome (IBS)
B
Note B · 4 études
Galactooligosaccharides (GOS) pour Irritable Bowel Syndrome (IBS)
B
Note B · 3 études
Lactobacillus acidophilus pour Irritable Bowel Syndrome (IBS)
D
Note B · 3 études
Fructooligosaccharides (FOS) pour Irritable Bowel Syndrome (IBS)
Note D · 2 études